Review of COVID-19 vaccine subtypes, efficacy and geographical distributions

AI Francis, S Ghany, T Gilkes… - Postgraduate medical …, 2022 - academic.oup.com
As of 1 May 2021, there have been 152 661 445 Covid-19 cases with 3 202 256 deaths
globally. This pandemic led to the race to discover a vaccine to achieve herd immunity and …

Management of COVID-19 vaccines cold chain logistics: a scoping review

ML Fahrni, IAN Ismail, DM Refi… - … policy and practice, 2022 - Taylor & Francis
Background Successful mass vaccination programmes are public health achievements of
the contemporary world. While pharmaceutical companies are actively developing new …

[HTML][HTML] Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India–a community based survey

KGM Danabal, SS Magesh, S Saravanan… - BMC Health Services …, 2021 - Springer
Background Effective and safe COVID 19 vaccines have been approved for emergency use
since the end of 2020 and countries are actively vaccinating their people. Nevertheless …

COVID-19 vaccine hesitancy among medical students in India

J Jain, S Saurabh, P Kumar, MK Verma… - Epidemiology & …, 2021 - cambridge.org
The coronavirus disease 2019 (COVID-19) vaccine was launched in India on 16 January
2021, prioritising health care workers which included medical students. We aimed to assess …

[HTML][HTML] COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey

S Umakanthan, S Patil, N Subramaniam, R Sharma - Vaccines, 2021 - mdpi.com
Background: The World Health Organization has recommended that individual governments
identify vaccine hesitancy areas. It is proposed that the governments, with the aid of local …

[HTML][HTML] Adenoviral vector-based vaccine platform for COVID-19: Current status

VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar… - Vaccines, 2023 - mdpi.com
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …

[HTML][HTML] COVID-19 vaccination hesitancy in India: State of the nation and priorities for research

S Chandani, D Jani, PK Sahu, U Kataria… - Brain, behavior, & …, 2021 - Elsevier
Background Few COVID-19 vaccines were anticipated in India in early 2021. However, little
was known about COVID-19 vaccination acceptance among the public. We conducted a …

[HTML][HTML] Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review

S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …

[HTML][HTML] Safety & effectiveness of COVID-19 vaccines: A narrative review

F Chirico, JAT da Silva, P Tsigaris… - Indian Journal of …, 2022 - journals.lww.com
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use
Authorization by the WHO that can offer some protection to the world's population during the …

[HTML][HTML] A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers-first results from India

U Kaur, B Ojha, BK Pathak, A Singh, KR Giri… - …, 2021 - thelancet.com
Background We provide the first post-approval safety analysis of COVISHIELD in health care
workers (HCWs) in northern India. Methods This continuing prospective observational study …